Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Nuvasive Inc (NUVA)

Nuvasive Inc (NUVA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,354,365
  • Shares Outstanding, K 52,046
  • Annual Sales, $ 1,102 M
  • Annual Income, $ 12,480 K
  • 60-Month Beta 1.14
  • Price/Sales 3.02
  • Price/Cash Flow 12.35
  • Price/Book 3.81

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/19
See More
  • Average Estimate 0.54
  • Number of Estimates 9
  • High Estimate 0.56
  • Low Estimate 0.49
  • Prior Year 0.56
  • Growth Rate Est. (year over year) -3.57%

Price Performance

See More
Period Period Low Period High Performance
1-Month
56.52 +14.03%
on 07/29/19
69.10 -6.73%
on 08/01/19
+6.33 (+10.89%)
since 07/19/19
3-Month
55.03 +17.12%
on 07/09/19
69.10 -6.73%
on 08/01/19
+2.83 (+4.59%)
since 05/20/19
52-Week
43.51 +48.13%
on 01/08/19
72.41 -10.99%
on 10/02/18
-4.48 (-6.50%)
since 08/20/18

Most Recent Stories

More News
Nuvasive Inc Set to Possibly Pullback After Yesterday's Rally of 1.30%

Nuvasive Inc (NASDAQ:NUVA) traded in a range yesterday that spanned from a low of $64.71 to a high of $65.29. Yesterday, the shares gained 1.3%, which took the trading range above the 3-day high of $64.94...

NUVA : 64.45 (+0.70%)
SmarTrend Watching for Potential Pullback in Shares of Nuvasive Inc After 1.30% Gain

Nuvasive Inc (NASDAQ:NUVA) traded in a range yesterday that spanned from a low of $64.71 to a high of $65.29. Yesterday, the shares gained 1.3%, which took the trading range above the 3-day high of $64.94...

NUVA : 64.45 (+0.70%)
NuVasive Expands its Advanced Materials Science(TM) Portfolio to Offer Porous Titanium Spine Implants for all TLIF Procedures

NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced the commercial...

NUVA : 64.45 (+0.70%)
Edwards Lifesciences' (EW) SAPIEN 3 TAVR Receives FDA Nod

Edwards Lifesciences (EW) plans a commercial introduction of SAPIEN 3 Ultra in Europe.

EW : 222.01 (-0.22%)
NUVA : 64.45 (+0.70%)
BAX : 86.97 (-1.02%)
MDT : 106.91 (+2.62%)
Here's Why You Should Hold Onto Omnicell (OMCL) Stock for Now

Investor confidence continues to be high on Omnicell's (OMCL) prospects.

OMCL : 70.69 (-0.11%)
NUVA : 64.45 (+0.70%)
BAX : 86.97 (-1.02%)
MDT : 106.91 (+2.62%)
QIAGEN Posts QIAstat-Dx Gastrointestinal Panel Study Results

The study outcome has been a major step for QIAGEN (QGEN) toward offering accurate diagnosis and treatment of gastroenteritis.

NUVA : 64.45 (+0.70%)
BAX : 86.97 (-1.02%)
QGEN : 34.17 (-1.84%)
MDT : 106.91 (+2.62%)
Baxter's PrisMax Adopted by Hamilton Health Care System

Baxter's (BAX) PrisMax System first adopted by Hamilton Health, which in turn is expected to enhance patient care.

SYK : 217.94 (-0.32%)
NUVA : 64.45 (+0.70%)
BAX : 86.97 (-1.02%)
HAE : 135.02 (-1.15%)
CVS Health Banks on Health Care Benefit Prospects Amid Woes

CVS Health's (CVS) recently introduced Health Care Benefits segment following the Aetna acquisition is gaining a strong momentum.

CVS : 61.56 (+0.28%)
NUVA : 64.45 (+0.70%)
BAX : 86.97 (-1.02%)
MDT : 106.91 (+2.62%)
ResMed (RMD) Hits a New 52-Week High: What's Driving It?

ResMed (RMD) gains from promising financial results in the fourth quarter of fiscal 2019.

NUVA : 64.45 (+0.70%)
RMD : 135.32 (-0.50%)
BAX : 86.97 (-1.02%)
MDT : 106.91 (+2.62%)
Here's Why You Should Hold Onto Insulet (PODD) Stock for Now

Investor confidence continues to be high on Insulet's (PODD) solid prospects.

NUVA : 64.45 (+0.70%)
BAX : 86.97 (-1.02%)
PODD : 152.43 (-0.07%)
MDT : 106.91 (+2.62%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy and ranks in the Top 1% of all short term signal directions.

Longer term, the trend strength is Good. Long term indicators fully support a continuation of the trend.

See More Share

Trade NUVA with:

Business Summary

NuVasive, Inc. is transforming spine surgery and beyond with minimally invasive, procedurally-integrated solutions designed to deliver reproducible and clinically-proven surgical outcomes. The Company's portfolio includes access instruments, implantable hardware, biologics, and software systems for surgical...

See More

Key Turning Points

2nd Resistance Point 66.04
1st Resistance Point 65.25
Last Price 64.45
1st Support Level 63.84
2nd Support Level 63.22

See More

52-Week High 72.41
Last Price 64.45
Fibonacci 61.8% 61.37
Fibonacci 50% 57.96
Fibonacci 38.2% 54.55
52-Week Low 43.51

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar